Cite
HARVARD Citation
Le Saux, O. et al. (n.d.). 63PEXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors. Annals of oncology. p. . [Online].